Vitamin E Supplementation in Alzheimer's Disease, Parkinson's Disease, Tardive Dyskinesia, and Cataract: Part 2
Authors:
- 1 December 2005
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 39 (12) , 2065-2072
Abstract
OBJECTIVE: To review clinical trials evaluating the safety and efficacy of vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract. DATA SOURCES: Using the MeSH terms alpha-tocopherol, tocopherols, vitamin E, Parkinson disease, tardive dyskinesia, Alzheimer disease, cataract, and clinical trials, a literature review was conducted to identify peer-reviewed articles in MEDLINE (1966–July 2005). STUDY SELECTION AND DATA EXTRACTION: Published materials including original research, review articles, and meta-analyses were reviewed. Only English-language articles and trials that included vitamin E alone or in combination with other vitamins or minerals were reviewed. Emphasis was placed on prospective, randomized, double-blind, placebo-controlled clinical trials. DATA SYNTHESIS: The clinical studies demonstrated contradicting results regarding the benefits of vitamin E in Parkinson's disease, tardive dyskinesia, and cataract. The study reviewed for Alzheimer's disease seemed to show benefit when vitamin E was used; however, the statistical methods employed are questionable. There is enough evidence from large, well-designed studies to discourage the use of vitamin E in Parkinson's disease, cataract, and Alzheimer's disease. We recommend that vitamin E be considered a treatment option in patients with tardive dyskinesia only if they are newly diagnosed. CONCLUSIONS: We encourage patients to supplement with vitamin E–rich foods. The use of a daily multivitamin, which usually contains 30 IU of alpha-tocopherol, may be beneficial; however, we discourage individual vitamin E supplements that usually contain 400 IU of alpha-tocopherol.Keywords
This publication has 65 references indexed in Scilit:
- Vitamin E Supplementation in Cardiovascular Disease and Cancer Prevention: Part 1Annals of Pharmacotherapy, 2005
- The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide DismutaseJournal of Clinical Psychopharmacology, 2004
- Mortality in DATATOP: A Multicenter trial in early Parkinson's diseaseAnnals of Neurology, 1998
- Dietary Antioxidants and Parkinson DiseaseArchives of Neurology, 1997
- Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control studyAnnals of Neurology, 1996
- The oxidant stress hypothesis in Parkinson's disease: Evidence supporting itAnnals of Neurology, 1992
- A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's diseaseAnnals of Neurology, 1992
- Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesiaBiological Psychiatry, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Case-Control Study of Early Life Dietary Factors in Parkinson's DiseaseArchives of Neurology, 1988